Oncolytics Biotech (ONCY) Tops Q3 EPS by 1c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
• B.Riley on Nayax (NYAX): 'Sell-Off Overshoots the Story'